Platelet glycoprotein Ibα polymorphisms and function evaluated by the platelet function analyzer PFA-100 in patients with lupus anticoagulant: The association with thromboembolic disease

Annals of Hematology

Volumn 86, Issue 10, 2007, Pages 719-725

  Jilma Stohlawetz, Petra ^a   Jilma, Bernd ^a   Mannhalter, Christine ^a   Bencur, Peter ^a   Pabinger, Ingrid ^a   Vormittag, Rainer ^a   Dunkler, Daniela ^a   Panzer, Simon ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Lupus anticoagulants; PFA 100; Platelet glycoprotein polymorphisms

Indexed keywords

ADRENALIN; COLLAGEN; GLYCOPROTEIN IB ALPHA; LUPUS ANTICOAGULANT; RISTOCETIN; THROMBIN RECEPTOR;

ADOLESCENT; ADULT; AGED; ANALYZER; ARTICLE; AUSTRIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; RISK ASSESSMENT; SCHOOL CHILD; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOEMBOLISM; VARIABLE NUMBER OF TANDEM REPEAT; ALLELE; BLOOD CLOTTING PARAMETERS; CHEMISTRY; COMPARATIVE STUDY; GENETICS; INSTRUMENTATION; MECHANICAL STRESS; METABOLISM; METHODOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; SHEAR STRENGTH; TANDEM REPEAT;

ADOLESCENT; ADULT; AGED; ALLELES; COLLAGEN; EPINEPHRINE; FEMALE; GENE FREQUENCY; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; PLATELET FUNCTION TESTS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; RETROSPECTIVE STUDIES; RISK FACTORS; SHEAR STRENGTH; STRESS, MECHANICAL; TANDEM REPEAT SEQUENCES; THROMBOEMBOLISM;

EID: 34548297581     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-007-0341-3     Document Type: Article

References (33)

1. Love PE, Santoro SA (1990) Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 112:682-698
2. Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346:752-763
3. Zoghlami-Rintelen C, Vormittag R, Sailer T, Lehr S, Quehenberger P, Rumpold H, Male C, Pabinger I (2005) The presence of IgG antibodies against beta2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant. J Thromb Haemost 3:1160-1165
4. Campbell AL, Pierangeli SS, Wellhausen S, Harris EN (1995) Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation. Thromb Haemost 73:529-534
5. Escolar G, Font J, Reverter JC, Lopez-Soto A, Garrido M, Cervera R, Ingelmo M, Castillo R, Ordinas A (1992) Plasma from systemic lupus erythematosus patients with antiphospholipid antibodies promotes platelet aggregation. Studies in a perfusion system. Arterioscler Thromb 12:196-200
6. Galli M, Bevers EM, Comfurius P, Barbui T, Zwaal RF (1993) Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles. Br J Haematol 83:466-472
7. Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ (2001) Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 115:451-459
8. Machin SJ (1996) Platelets and antiphospholipid antibodies. Lupus 5:386-387
9. Martinuzzo ME, Maclouf J, Carreras LO, Levy-Toledano S (1993) Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation. Thromb Haemost 70:667-671
10. Slupsky JR, Cawley JC, Griffith LS, Shaw AR, Zuzel M (1992) Role of Fc gamma RII in platelet activation by monoclonal antibodies. J Immunol 148:3189-3194
11. Wang L, Su CY, Chou KY, Wang CT (2002) Enhancement of human platelet activation by the combination of low concentrations of collagen and rabbit anticardiolipin antibodies. Br J Haematol 118:1152-1162
12. Arvieux J, Roussel B, Pouzol P, Colomb MG (1993) Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I. Thromb Haemost 70:336-341
13. Deckmyn H, Ulrichts H, Van De Walle G, Vanhoorelbeke K (2004) Platelet antigens and their function. Vox Sang 87(Suppl 2):105-111
14. Yee DL, Bray PF (2004) Clinical and functional consequences of platelet membrane glycoprotein polymorphisms. Semin Thromb Hemost 30:591-600
15. Lopez JA, Ludwig EH, McCarthy BJ (1992) Polymorphism of human glycoprotein Ib alpha results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. Structure/function implications. J Biol Chem 267:10055-10061
16. Afshar-Kharghan V, Li CQ, Khoshnevis-Asl M, Lopez JA (1999) Kozak sequence polymorphism of the glycoprotein (GP) Ibalpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex. Blood 94:186-191
17. Jilma-Stohlawetz P, Homoncik M, Jilma B, Knechtelsdorfer M, Unger P, Mannhalter C, Santoso S, Panzer S (2003) Glycoprotein Ib polymorphisms influence platelet plug formation under high shear rates. Br J Haematol 120:652-655
18. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
19. Brandt JT, Triplett DA, Alving B, Scharrer I (1995) Criteria for the diagnosis of lupus anticoagulants: An update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 74:1185-1190
20. Schallmoser K, Rosin C, Knittelfelder R, Sailer T, Ulrich S, Zoghlami C, Lehr S, Pabinger I, Panzer S (2005) The Fc gammaRIIa polymorphism R/ H131, autoantibodies against the platelet receptors GPIb alpha and Fc gammaRIIa and a risk for thromboembolism in lupus anticoagulant patients. Thromb Haemost 93:544-548
21. Jilma B (2001) Platelet function analyzer (PFA-100): A tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 138:152-163
22. Homoncik M, Jilma B, Hergovich N, Stohlawetz P, Panzer S, Speiser W (2000) Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Thromb Haemost 83:316-321
23. Reiter RA, Mayr F, Blazicek H, Galehr E, Jilma-Stohlawetz P, Domanovits H, Jilma B (2003) Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. Blood 102:4594-4599
24. Schallmoser K, Rosin C, Vormittag R, Brunner M, Dunkler D, Pabinger I, Panzer S (2006) Specificities of platelet autoantibodies and platelet activation in lupus anticoagulant patients: A relation to their history of thromboembolic disease. Lupus 15:507-514
25. Harrison P, Robinson MS, Mackie IJ, Joseph J, McDonald SJ, Liesner R, Savidge GF, Pasi J, Machin SJ (1999) Performance of the platelet function analyser PFA-100 in testing abnormalities of primary haemostasis. Blood Coagul Fibrinolysis 10:25-31
26. Out HJ, de Groot PG, van Vliet M, de Gast GC, Nieuwenhuis HK, Derksen RH (1991) Antibodies to platelets in patients with anti-phospholipid antibodies. Blood 77:2655-2659
27. Panzer S, Gschwandtner ME, Hutter D, Spitzauer S, Pabinger I (1997) Specificities of platelet autoantibodies in patients with lupus anticoagulants in primary antiphospholipid syndrome. Ann Hematol 74:239-242
28. Rock G, Chauhan K, Jamieson GA, Tandon NN (1994) Anti-CD36 antibodies in patients with lupus anticoagulant and thrombotic complications. Br J Haematol 88:878-880
29. Macchi L, Rispal P, Clofent-Sanchez G, Pellegrin JL, Nurden P, Leng B, Nurden AT (1997) Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: their relationship with the observed thrombocytopenia. Br J Haematol 98:336-341
30. Godeau B, Piette JC, Fromont P, Intrator L, Schaeffer A, Bierling P (1997) Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome. Br J Haematol 98:873-879
31. Galli M, Daldossi M, Barbui T (1994) Anti-glycoprotein Ib/IX and IIb/ IIIa antibodies in patients with antiphospholipid antibodies. Thromb Haemost 71:571-575
32. Levy Y, Shenkman B, Tamarin I, Pauzner R, Shoenfeld Y, Langevitz P, Savion N, Varon D (2005) Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events. Arthritis Rheum 52:4011-4017
33. Sailer T, Vormittag R, Pabinger I, Vukovich T, Lehr S, Quehenberger P, Panzer S, Lechner K, Zoghlami-Rintelen C (2005) Inflammation in patients with lupus anticoagulant and implications for thrombosis. J Rheumatol 32:462-468